Others Products Targets
- Voltage-gated Sodium (NaV) Channel (30)
- Voltage-gated Potassium (KV) Channel (38)
- Voltage-gated Calcium Channel (CaV) (38)
- TRPV (30)
- NFKB and IKB (30)
- GABAB Receptor (28)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Bradykinin Receptor (12)
- Others (20)
- Glucocorticoid Receptor (9)
- Cytokine Receptor (4)
- Cyclooxygenase (24)
- IRAK (1)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- Glutamate (Metabotropic) Group III Receptor (26)
- Glutamate (Metabotropic) Group II Receptor (33)
- Glutamate (Metabotropic) Group I Receptor (54)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- NK3 Receptor (5)
- NMDA Receptor (87)
- Kainate Receptor (22)
- CCK2 Receptor (7)
- CCK1 Receptor (3)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Delta opioid receptor (16)
- Purinergic (P2X) Receptor (32)
- Prostanoid Receptor (24)
Products for Others - Page 15
- Cat.No. Product Name Information/Activity
-
BCC3602
KN-62
KN-62 is a selective and potent inhibitor of calmodulin-dependent protein kinase II (CaMK-II) with IC50 of 0.9 μM, KN-62 also displays noncompetitive antagonism at P2X7 receptors in HEK293 cells, with an IC50 value of approximately 15 nM.
-
BCC6985
NF 023
104869-31-0
-
BCC7404
NF 110
111150-22-2
-
BCC7367
NF 157
NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA).
-
BCC6964
NF 279
202983-32-2
-
BCC7043
NF 449
Highly selective P2X<sub>1</sub> antagonist
-
BCC6725
PPADS tetrasodium salt
PPADS tetrasodiuma is a non-selective P2X receptor antagonist. PPADS tetrasodiuma blocks recombinant P2X1, -2, -3, -5 with IC50s ranging from 1 to 2.6 μM. PPADS tetrasodiuma blocks native P2Y2-like (IC50~0.9 mM) and recombinant P2Y4 (IC50~15 mM) receptors. PPADS tetrasodiuma is an inhibitor of the reverse mode of the Na/Ca²⁺exchanger in guinea pig airway smooth muscle.
-
BCC6749
iso-PPADS tetrasodium salt
P2X antagonist
-
BCC7015
PPNDS
1021868-77-8
-
BCC7276
Ro 0437626
134362-79-1


